Advanced Clinical Research represents the vanguard of medical exploration, going beyond conventional methodologies. It integrates state-of-the-art technologies like AI and big data, fostering a data-driven understanding of diseases. This interdisciplinary field unites genomics, pharmacology, and bioinformatics experts, promoting personalized medicine and targeted therapies. The emphasis on biomarkers and diagnostics enhances precision, enabling faster, more efficient clinical trials. Adaptive trial designs, a hallmark of Advanced Clinical Research, optimize resources and expedite drug development. The field also delves into the intricate role of the human microbiome, paving the way for therapies targeting the gut-brain axis.
Ethical considerations remain paramount, with a focus on patient-reported outcomes and active patient engagement. In essence, Advanced Clinical Research is reshaping the future of medicine, emphasizing innovation, efficiency, and patient-centricity in the relentless pursuit of improved healthcare outcomes. Advanced Clinical Research is a dynamic and forward-looking field that transcends traditional boundaries. Through the integration of cutting-edge technologies, interdisciplinary collaboration, and a patient-centric approach, researchers in this field are driving innovation and revolutionizing the landscape of healthcare. As the journey of discovery continues, the impact of Advanced Clinical Research is poised to shape the future of medicine, bringing hope and healing to patients around the globe.
Title : Ectopically expressed olfactory receptors as an untapped family of drug targets and discovery of agonists and antagonists of OR51E1, an understudied G protein-coupled receptor
Vladlen Slepak, University of Miami Miller School of Medicine, United States
Title : Managing healthcare transformation towards personalized, preventive, predictive, participative precision medicine ecosystems
Bernd Blobel, University of Regensburg, Germany
Title : Analytical strategies for solid-state forms in drug development
Maria Cristina Gamberini, University of Modena e Reggio Emilia, Italy
Title : Understanding drug transport in plasma: The role of protein binding
Saad Tayyab, UCSI University, Malaysia
Title : Innovative development and delivery of biologics for chronic obstructive pulmonary disease
Yong Xiao Wang, Albany Medical College, United States
Title : Search for novel biomarkers and therapeutic targets for inflammatory disease
Madhav Bhatia, University of Otago, New Zealand
Title : Personalized and Precision Medicine (PPM) as a unique healthcare model through de-sign-inspired biotech- & biopharma-driven applications and upgraded business mar-keting to secure the human healthcare and biosafety
Sergey Suchkov, N.D. Zelinskii Institute for Organic Chemistry of the Russian Academy of Sciences & InMedStar, Russian Federation
Title : Design and evaluation of exo-itc: A bilayer fibrous system for controlled exosome delivery in dermatological applications
Luis Jesus Villarreal Gomez, FCITEC - Universidad AutĂłnoma de Baja California, Mexico
Title : Abuse-deterrent dosage form technique utilizing a fusion of innovative pharmaceuticals and ion exchange resin
Bhupendra Gopalbhai Prajapati, Parul University, India
Title : Macitentan/tadalafil combination– An additional value in pharmacotherapy of pulmonary arterial hypertension
Miroslav Radenkovic, University of Belgrade, Serbia